Background & Aims Despite rescue therapy, more than 30% of patients with acute severe
ulcerative colitis (ASUC) require colectomy. Tofacitinib is a rapidly acting Janus kinase …

Background Safety of anti-tumour necrosis factor-α (TNFα) therapy in people with a history
of cancer and with an immune-mediated disease is unknown. We aimed to assess the risk of …

Background Dual targeted therapy (DTT) has emerged as an attractive therapeutic option
for select patients with active inflammatory bowel disease (IBD) who are unable to achieve …

Background Pain is commonly experienced by patients with inflammatory bowel disease (IBD).
Unfortunately, pain management is a challenge in IBD care, as currently available …

Background Patients with inflammatory bowel disease (IBD) are at increased risk for pneumonia,
and corticosteroids are reported to amplify this risk. Less is known about the impact of …

Background Inflammatory bowel disease (IBD) is associated with substantial symptom
burden, variability in clinical outcomes, and high direct costs. We sought to determine if a care …

Background In response to the COVID-19 pandemic, the CDC issued guidance advising
patients and providers to adopt social distancing practices such as home-based infusions (H-BI)…

Background High-deductible health plans (HDHPs) are increasing in prevalence as a cost
control device for slowing health care cost growth by reducing nonessential medical service …

Background and study aims Acute pancreatitis (AP) is an increasingly common indication
for hospitalization in the United States. The necessity for endoscopic retrograde …

BACKGROUND & AIMS Acute severe ulcerative colitis (ASUC) is a life-threatening
presentation of ulcerative colitis requiring prompt treatment. Infliximab (IFX) rescue therapy can …